Kailera Therapeutics, Inc. (KLRA) Insider Trading
Sector: Biotechnology · Market Cap: $2.9B · 0 insider purchases in the last 7 days
No open market insider purchases at Kailera Therapeutics, Inc. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track KLRA on your watchlist.
Start for FreeAbout Kailera Therapeutics, Inc. Insider Trading
5 insiders at Kailera Therapeutics, Inc. (KLRA) have purchased stock in the past 90 days, totaling $326.8M across 5 transactions (20,421,876 shares).
The most recent purchase was by 10%+ Owner RTW INVESTMENTS, LP on April 20, 2026 — a $8.0M buy of 500,000 shares at $16.00, bringing his total holdings to 10,776,820 shares.
Insiders who purchased: BAIN CAPITAL INVESTORS LLC (10%+ Owner, 1 buy totaling $134.4M); Kaplan Andrew T. (Director, 1 buy totaling $134.4M); Bain Capital Life Sciences Investors, LLC (10%+ Owner, 1 buy totaling $25.0M); Koppel Adam (Director, 1 buy totaling $25.0M); RTW INVESTMENTS, LP (10%+ Owner, 1 buy totaling $8.0M).
This insider buying is notable given that KLRA had no recorded open market purchases in the nine months before that.
KLRA is in the Biotechnology sector within the Biotechnology industry with a market cap of $2.9B.
With 5 different insiders buying in the same 90-day window, this qualifies as cluster buying at KLRA — a pattern that research suggests can signal conviction among management.
Track KLRA insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.